Clinical Trials Browser

Completed × Prostatic Neoplasms × cediranib × Clear all

NCT00436956 2018-10-09

AZD2171 to Treat Prostate Cancer

Phase 2 Completed

59 enrolled 12 charts

Prostatic Neoplasms

NCT01260688 2018-08-08

Cediranib Maleate With or Without Dasatinib in Patients With HRPC-Resistant to Treatment With Docetaxel

Phase 2 Completed

22 enrolled 23 charts

Prostatic Neoplasms